EQ-5D Value Sets

Inventory, Comparative Review and User Guide

  • AGOTA SZENDE
  • MARK OPPE
  • NANCY DEVLIN

Part of the EuroQol Group Monographs book series (EQOL, volume 2)

Table of contents

  1. Front Matter
    Pages 1-11
  2. Rosalind Rabin, Frank de Charro, Agota Szende
    Pages 13-19
  3. Agota Szende, Mark Oppe, Frank de Charro
    Pages 21-28
  4. Mark Oppe, Agota Szende, Frank de Charro
    Pages 29-38
  5. Nancy Devlin, David Parkin
    Pages 39-52
  6. Back Matter
    Pages 53-102

About this book

Introduction

Rosalind Rabin, Frank de Charro, Agota Szende 1.1 Purpose of this booklet Governments and healthcare funders worldwide are making increasing use of economic evaluation to inform priority setting in health care. For various reasons, cost benefit analysis is usually rejected in favour of cost-effectiveness or cost-utility analyses, often involving the estimation of the incremental cost per Quality Adjusted Life Year (QALY) gained (Drummond et al, 2005). The estimation of QALYs gained requires valuations for all relevant health states on a scale anchored at 1 = Full health and 0 = Dead. The EQ-5D is widely used in this context and a number of value sets are available for all the health states generated by the EQ-5D descriptive system. These can be readily applied to health outcomes measured as EQ-5D profiles. EQ-5D has become one of the valuation approaches recommended by several reimbursement authorities and academic bodies in European countries (e.g. The Netherlands, Norway, Italy, Hungary, Poland, Portugal, UK), North America (e.g. Canada), and elsewhere (e.g. New Zealand). The EuroQol Group frequently receives requests for advice regarding EQ-5D valuation data. Those seeking to apply EQ-5D valuations in economic evaluation want to know about the availability of EQ-5D value sets and how they can obtain them. They also seek specific guidance about which of the available value sets they should use for their purposes.

Keywords

Excel Public Health Radiologieinformationssystem health social medicine

Editors and affiliations

  • AGOTA SZENDE
    • 1
  • MARK OPPE
    • 2
  • NANCY DEVLIN
    • 3
  1. 1.Covance Market Access ServicesLeedsU.K.
  2. 2.Institute for Medical Technology Assessment, Erasmus MCRotterdamThe Netherlands
  3. 3.City UniversityLondonU.K.

Bibliographic information

  • DOI https://doi.org/10.1007/1-4020-5511-0
  • Copyright Information Springer 2007
  • Publisher Name Springer, Dordrecht
  • eBook Packages Medicine
  • Print ISBN 978-1-4020-5510-2
  • Online ISBN 978-1-4020-5511-9
  • About this book